Free Trial

Blair William & Co. IL Has $12.80 Million Stock Holdings in Cigna Group (NYSE:CI)

Cigna Group logo with Medical background

Blair William & Co. IL cut its stake in shares of Cigna Group (NYSE:CI - Free Report) by 3.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,894 shares of the health services provider's stock after selling 1,511 shares during the period. Blair William & Co. IL's holdings in Cigna Group were worth $12,796,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CI. Evermay Wealth Management LLC lifted its position in shares of Cigna Group by 58.6% in the first quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider's stock valued at $37,000 after buying an additional 41 shares during the last quarter. Richardson Financial Services Inc. acquired a new stake in shares of Cigna Group in the first quarter valued at approximately $38,000. Wayfinding Financial LLC acquired a new stake in shares of Cigna Group in the first quarter valued at approximately $40,000. Putney Financial Group LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $36,000. Finally, Transce3nd LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $38,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $267.26 on Tuesday. The company has a market cap of $71.34 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 0.79 and a beta of 0.47. Cigna Group has a 52 week low of $256.89 and a 52 week high of $370.83. The business has a 50 day moving average price of $307.92 and a 200-day moving average price of $312.21. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%. The company's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the business posted $6.72 earnings per share. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is presently 32.97%.

Analysts Set New Price Targets

CI has been the topic of a number of recent research reports. Wall Street Zen lowered Cigna Group from a "buy" rating to a "hold" rating in a research note on Saturday. Morgan Stanley increased their target price on Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Robert W. Baird lowered their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Barclays lowered their target price on Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a research note on Friday. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $376.56.

Read Our Latest Report on CI

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines